Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other financing activities (2021 - 2022)

Rani Therapeutics Holdings has reported Other financing activities over the past 2 years, most recently at $152000.0 for Q4 2022.

  • Quarterly results put Other financing activities at $152000.0 for Q4 2022, changed N/A from a year ago — trailing twelve months through Dec 2022 was $260000.0 (changed N/A YoY), and the annual figure for FY2022 was $260000.0, changed.
  • Other financing activities for Q4 2022 was $152000.0 at Rani Therapeutics Holdings, up from $108000.0 in the prior quarter.
  • Over the last five years, Other financing activities for RANI hit a ceiling of $2.2 million in Q2 2021 and a floor of -$1.9 million in Q3 2021.